DGX fund manager activity
Quest Diagnostics Incorporated · NYSE. Reported by 14 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Steven Check - Check Capital Management | No change | 1,300 | $275,536 | 0.02% | Aug 5, 2026 |
| Christopher Davis - Davis Advisors | Trimmed | 1,555,612 | $329,781,509 | 1.42% | Aug 11, 2026 |
| First Eagle Investment Management | Added | 7,606 | $1,612,092 | 0.00% | Aug 24, 2026 |
| Jeremy Grantham - GMO | Added | 1,888,207 | $400,206,122 | 0.90% | Aug 13, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 117,533 | $24,911,119 | 0.06% | Aug 14, 2026 |
| Lee Ainslie - Maverick Capital | Sold out | — | — | 0.00% | Aug 14, 2026 |
| Robert Olstein - Olstein Capital Management | Sold out | — | — | 0.00% | Jul 7, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Steven Check - Check Capital Management | No change | 1,300 | $254,775 | 0.02% | May 4, 2026 |
| Christopher Davis - Davis Advisors | Added | 1,617,813 | $317,062,477 | 1.46% | May 7, 2026 |
| First Eagle Investment Management | Trimmed | 3,000 | $587,940 | 0.00% | May 14, 2026 |
| Ken Fisher - Fisher Asset Management | Sold out | — | — | 0.00% | May 5, 2026 |
| Jeremy Grantham - GMO | Added | 1,883,024 | $369,035,502 | 0.94% | May 14, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 130,777 | $25,629,676 | 0.08% | May 15, 2026 |
| Lee Ainslie - Maverick Capital | Trimmed | 2,756 | $540,121 | 0.01% | May 15, 2026 |
| Robert Olstein - Olstein Capital Management | Trimmed | 35,800 | $7,016 | 1.53% | Apr 21, 2026 |